| Metric | Q4'25 | Q1'26 | Change |
|---|---|---|---|
| Net Sales | $942M (-12% YoY) | $1.06B (+12% YoY) | 24 percentage point swing to positive growth |
| C&I Segment Sales | $399M (+10% YoY) | $510M (+28% YoY) | 1,800 bps acceleration |
| Residential Segment Sales | $549M (-23% YoY) | $552M (+1% YoY) | 24 percentage point swing from deep decline |
| Consolidated Gross Margin | 39.5% | 38.7% | 80 bps decline despite strong execution |
| Adjusted EBITDA Margin | 15.9% | 18.3% | 240 bps expansion on operating leverage |
| Residential EBITDA Margin | 20.3% | 25.1% | 480 bps expansion from OpEx recalibration |
| C&I EBITDA Margin | 11.4% | 13.0% | 160 bps improvement on scale |
| Free Cash Flow | $27M | $90M | 233% improvement on working capital efficiency |
| C&I Backlog | ~$400M | $700M+ | $300M increase in 10 weeks |
| Domestic Manufacturing Capacity | $500M globally | >$1B domestic by Q4 | 100% capacity expansion underway |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.